Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
2016 · EBioMedicine · 99 citations
https://doi.org/10.1016/j.ebiom.2016.04.032
J
Jane Gilmour
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
1.2K
Citations
16
h-index
18
i10-index
Jane Gilmour is an academic researcher from University of Birmingham. The author has contributed to research in topics: Epigenetics and DNA Methylation & Acute Myeloid Leukemia Research & Immune Cell Function and Interaction. The author has an h-index of 16, co-authored 27 publications.
Papers by this author
worksCorrigendum to: “Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers” [EBioMedicine 8 (2016) 117–131]
2017 · EBioMedicine · 1 citations
https://doi.org/10.1016/j.ebiom.2017.10.029
MOESM3 of Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8227979
MOESM2 of Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8227976
MOESM4 of Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8227985
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat